Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis
Keywords:
Efficacy, mometasone furoate, tacrolimus, atopic dermatitisAbstract
Objective To compare the efficacy of mometasone furoate and tacrolimus in the treatment of atopic dermatitis. Methods Sixty patients of atopic dermatitis were treated with mometasone furoate 0.1% (n=30) and tacrolimus 0.03% (n=30). Both treatments were applied twice daily for 12 weeks. Patients were followed up monthly. The disease severity assessed by SCORAD index. A 4-point scale was used to measure the level of response to treatment. Results Before treatment the respective mean SCORAD was 30.57±13.62 and 30.90±17.17 in group A and B and at the end of treatment decreased to 11.87±12.04 and 11.20±13.85, respectively (p>0.05). Percent reduction of severity from baseline to final follow-up was 69.20±23.41 in group A and 74.77±23.30 in group B (p=0.360). At final follow-up 56.7% of group A and 63.3% of group B achieved excellent response, 13.3% of group A and 16.7% of group B achieved good response.  Conclusion We conclude that both treatments, mometasone furoate and tacrolimus, are effective in the treatment of atopic dermatitis.ÂReferences
Atherton DJ. Topical corticosteroids in atopic dermatitis. Recent research reassures that they are safe and effective in the medium term. BMJ. 2003;327: 942- 3.
Green C, Colquitt JL, Kirby J et al. Clinical and cost-effectiveness of once daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess. 2004;8:1-120.
Hauser C, Wuetrich B, Matter L et al. Staphylococcus aureus skin colonization in atopic dermatitis. Dermatologica. 1985;170:35-9.
McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin secreting potential of staphylococci isolated from eczematous skin. Br J Dermatol. 1993;128:631-2.
Dhar S. Should topical antibacterials be routinely combined with topical steroids in the treatment of atopic dermatitis? Indian J Dermatol Venereol Leprol. 2005;71:71-2.
Proksch E. The role of emollients in the management of diseases with chronic dry skin. Skin Pharmacol Physiol. 2008;21:75-80.
Eichenfield LF, Hanifin JM, Luger TA et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49:1088-95.
Gambichler T. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005;52:660-70.
Rajka G, Avrach W, Gartner L, Overgaard-Petersen H. Mometasone furoate 0.1% fatty cream once daily versus betamethasone valerate 0.1% cream twice daily in the treatment of patients with atopic and allergic contact dermatitis. Cur Ther Res Clin Exp. 2005;54:23-9.
Hoybye S, Balk MS, De Cunha BF et al. Continuous and intermittent treatment of atopic dermatitis in adults with mometasone furoate versus hydrocortisone 17-butyrate. Cur Ther Res Clin Exp. 2004;50:67-72.
Stalder JF, Tateb A. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology. 2006:186:23-31.
Williams H. New treatments for atopic dermatitis. BMJ. 2002;324:1533-4.
Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: an overview. Br J Dermatol. 2003;139:763-6.
Gradman J, Wolthers OD. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children. Pediatr Dermatol. 2008;25:269-70.
Pei AY, Chan HH, Ho KM. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol. 2001;18:343-8.
Schnopp C, Holtmann C, Stock S et al. Topical steroids under wet-wrap dressings in atopic dermatitis—a vehicle-controlled trial. Dermatology. 2002;204:56-9.
Hoeger PH, Lee KH, Jautova J et al. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Br J Dermatol. 2009;160:415-22. Epub 2008 Nov 25.
Zuberbier T, Bräutigam M. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. J Eur Acad Dermatol Venereol. 2008;22:718-21.
